Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-F Riou

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Annals of the New York Academy of Sciences|February 10, 2000
Cellular effects of a new farnesyltransferase inhibitor, RPR-115135, in a human isogenic colon cancer cell line model system HCT-116P Russo, C Ottoboni, C Falugi, et al.
FEBS Letters|November 4, 1996
DNA topoisomerase I changes the mode of interaction between camptothecin drugs and DNA as probed by UV-resonance Raman spectroscopyA V Feofanov, A V Baranov, F Fleury, et al.
Physical Review Letters|April 12, 2006
Beam quality of a nonideal atom laserJ-F Riou, W Guerin, Y Le Coq, et al.
Nature|December 21, 1989
Alternative splicing directs the expression of two D2 dopamine receptor isoformsB Giros, P Sokoloff, M P Martres, et al.
In Vivo (Athens, Greece)|September 1, 1991
The amphibian embryo: an experimental model for the in vivo analysis of interactions between embryonic cells and extracellular matrix moleculesJ C Boucaut, T Darribere, D L Shi, et al.
European Journal of Medicinal Chemistry|August 30, 2001
Synthesis and biological evaluation of O-alkylated tropolones and related alpha-ketohydroxy derivatives as ribonucleotide reductase inhibitorsI Tamburlin-Thumin, M P Crozet, J C Barrière, et al.
Biochemical Pharmacology|October 19, 1993
The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and IIA K Larsen, L Grondard, J Couprie, et al.
Anti-Cancer Drug Design|June 1, 1995
Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agentsC H Nguyen, E Fan, J F Riou, et al.
The International Journal of Developmental Biology|December 1, 1994
Tenascin expression in developing, adult and regenerating caudal spinal cord in the urodele amphibiansX Caubit, J F Riou, J Coulon, et al.
Chemical Communications (Cambridge, England)|February 3, 2018
Binding properties of mono- and dimeric pyridine dicarboxamide ligands to human telomeric higher-order G-quadruplex structuresC Saintomé, P Alberti, N Guinot, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Annals of the New York Academy of Sciences|February 10, 2000
Cellular effects of a new farnesyltransferase inhibitor, RPR-115135, in a human isogenic colon cancer cell line model system HCT-116P Russo, C Ottoboni, C Falugi, et al.
FEBS Letters|November 4, 1996
DNA topoisomerase I changes the mode of interaction between camptothecin drugs and DNA as probed by UV-resonance Raman spectroscopyA V Feofanov, A V Baranov, F Fleury, et al.
Physical Review Letters|April 12, 2006
Beam quality of a nonideal atom laserJ-F Riou, W Guerin, Y Le Coq, et al.
Nature|December 21, 1989
Alternative splicing directs the expression of two D2 dopamine receptor isoformsB Giros, P Sokoloff, M P Martres, et al.
In Vivo (Athens, Greece)|September 1, 1991
The amphibian embryo: an experimental model for the in vivo analysis of interactions between embryonic cells and extracellular matrix moleculesJ C Boucaut, T Darribere, D L Shi, et al.
European Journal of Medicinal Chemistry|August 30, 2001
Synthesis and biological evaluation of O-alkylated tropolones and related alpha-ketohydroxy derivatives as ribonucleotide reductase inhibitorsI Tamburlin-Thumin, M P Crozet, J C Barrière, et al.
Biochemical Pharmacology|October 19, 1993
The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and IIA K Larsen, L Grondard, J Couprie, et al.
Anti-Cancer Drug Design|June 1, 1995
Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agentsC H Nguyen, E Fan, J F Riou, et al.
The International Journal of Developmental Biology|December 1, 1994
Tenascin expression in developing, adult and regenerating caudal spinal cord in the urodele amphibiansX Caubit, J F Riou, J Coulon, et al.
Chemical Communications (Cambridge, England)|February 3, 2018
Binding properties of mono- and dimeric pyridine dicarboxamide ligands to human telomeric higher-order G-quadruplex structuresC Saintomé, P Alberti, N Guinot, et al.
Pageof 11